Praxbind 2.5 g
As listed in the register: Praxbind 2.5 g, Injektions- bzw. Infusionslösung
2.5 g ·
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Idarucizumabum
- Made by
- Boehringer Ingelheim (Schweiz) GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Praxbind ist zur Aufhebung der antikoagulativen Wirkung von Pradaxa bestimmt
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Boehringer Ingelheim (Schweiz) GmbH |
|---|---|
| Active substance | Idarucizumabum |
| Used in | Everything that fits nowhere else, such as contrast media |
| Strength | 2.5 g |
| Classification | V03AB37 · Everything that fits nowhere else, such as contrast media |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Praxbind 2.5 g, Injektions- bzw. Infusionslösung |
| Packs | 2x50 ml Durchstechflasche(n) |
| Zulassungsnummer | 65804 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.